Search

Author/Creator Versele, Matthias

1. Identification of potential ibrutinib combinations in hematological malignancies using a combination high-throughput screen. Issue 4 (3rd April 2018)

Authors:
Schaffer, Michael; Chaturvedi, Shalini; Davis, Cuc; Aquino, Regina; Stepanchick, Emily; Versele, Matthias; Liu, Yang; Yang, Jennifer; Lu, Rongzhen; Balasubramanian, Sriram
Journal:
Leukemia & lymphoma
Issue:
Volume 59:Issue 4(2018)
Page Start:
931
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. The effect of Bruton's tyrosine kinase (BTK) inhibitors on collagen‐induced platelet aggregation, BTK, and tyrosine kinase expressed in hepatocellular carcinoma (TEC). (24th September 2018)

Authors:
Chen, Jun; Kinoshita, Taisei; Gururaja, Tarikere; Sukbuntherng, Juthamas; James, Danelle; Lu, Daniel; Whang, Jennifer; Versele, Matthias; Chang, Betty Y.
Journal:
European journal of haematology
Issue:
Volume 101:Number 5(2018)
Page Start:
604
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. TMOD-22. DIFFERENTIAL DRUG SENSITIVITY ANALYSIS IN PAIRED PATIENT-DERIVED CELL LINES OF GLIOBLASTOMA. (12th November 2021)

Authors:
Panovska, Dena; Shetty, Aniket; Derweduwe, Marleen; Claeys, Annelies; Van der Voordt, Marine; Smets, Tina; Versele, Matthias; Monaco, Giovanni; De Moor, Bart; Chaltin, Patrick; Clement, Paul; Ligon, Keith; De Vleeschouwer, Steven; Sciot, Raf; Pey, Jon; Antoranz, Asier; De Smet, Frederik
Journal:
Neuro-oncology
Issue:
Volume 23: Supplement 6(2021)
Page Start:
vi220
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗